AzTrials
AzTrials

Hearing LossLACENCT00727337

Supplementing Hearing Aids With Computerized Auditory Training

A study testing LACE-computer and Lace-DVD in people with Hearing Loss, run by VA Office of Research and Development at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study is designed to examine the effectiveness of a computer-based auditory training program to improve the benefits received by individuals who wear hearing aids. The study will involve 3 groups - a computer-based training group, an active listening group which will involve listening to books on CD, and a placebo… Read more about this study

Who is it for?
Ages 55 to 85 years
Conditions the study is for
Hearing Loss
What is being tested?
LACE-computer and Lace-DVD
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
279 participants
Where
1 siteUnited States
Study dates
Jan 2009to Dec 2011
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • adult onset hearing loss,
  • English as the first language,
  • bilateral, symmetric, sensorineural hearing loss,
  • average audiometric thresholds for 500, 1000, and 2000 Hz less than 50-dB HL in either ear,
  • aided speech recognition in quiet of 40% binaurally,
  • appropriate cognitive skills assessed using the Mini Mental State Exam (Folstein et al., 1975) with age/education norms (Crum et al., 1993),
  • adequate vision to participate in the study as determined with the Smith-Kettlewell Institute Low Luminance (SKILL) Card,
  • eligible for VA-issued hearing aids.

Who cannot join

  • known neurological, psychiatric disorders, or co-morbid diseases that would prevent completion of the study as determined by chart review,

Trial locations and contacts

1 site in 1 country.

United States1 site
  • VA Medical Center, Bay Pines

    Bay Pines, Florida, 33708

Other trials in United States

About this study

The study is designed to examine the effectiveness of a computer-based auditory training program to improve the benefits received by individuals who wear hearing aids. The study will involve 3 groups - a computer-based training group, an active listening group which will involve listening to books on CD, and a placebo group that receives no additional treatment.

Read the detailed description

This proposed study is a multi-site, single-masked (blinded), randomized controlled, parallel group clinical trial to assess the effectiveness of an at home PC-based auditory training as a supplement to standard-of-care hearing-aid intervention in veterans treated for hearing loss, with or without previous hearing-aid experience. The participants will be assigned randomly to one of three groups, with hearing-aid use stratified within the groups: (1) Group 1, HA+AT, in which the participants will receive standard-of-care hearing-aid intervention (HA) and complete the four-week LACE auditory training program (AT); (2) Group 2, HA, with the participants receiving only standard-of-care hearing-aid intervention (HA); and (3) Group 3, HA+DL, in which the participants will receive standard-of-care hearing-aid intervention (HA) and complete four-weeks of placebo auditory training, consisting of directed listening (DL) to books-on-tape. The participants in each group will attend four test sessions. During Session 1 the informed consent process will be completed, baseline assessments will be made to ensure that the participants meet the study inclusion criteria (page 52), testing of predictor variables (page 57-58) will be completed, and all hearing aids will be assessed for correct functionality (page 53). The participants then will be assigned randomly to a study group. Session 2 will occur four weeks after Session 1. During Session 2, baseline performance on the outcome measures will be assessed (page 54-57), as will performance on the predictor variables. Following testing, the participants in Groups 1 and 3 will receive training in the use of the AT or DL programs. Session 3 will occur at the end of the 4-week experimental training period. During Session 3 all participants will be retested on the outcome measures to assess short-term intervention outcomes. During Session 4, which will occur at seven-months post-study enrollment (i.e., six-months post training completion for Groups 1 and 3), all participants will be retested on all outcome measures to examine the long-term outcomes. In Sessions 2-4, the stability of hearing-aid function will be assessed through electroacoustic measures.

Conditions
Hearing Loss
Being tested
LACE-computer, PLACEBO-Directed listening, CONTROL, Lace-DVD
Keywords
auditory perception, rehabilitation of hearing impaired
Medical subject headings
Hearing Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • LACE-computerBehavioural

    Computerized Auditory Training

  • PLACEBO-Directed listeningBehavioural

    Subjects will be asked to listen to books on tape for 20 minutes a day and answer questions as they go along

  • CONTROLBehavioural

    No specialized treatment will be provided in addition to standard of care audiology treatment provided with the provision of hearing aids

  • Lace-DVDBehavioural

    DVD based Auditory Training

Study groups in NCT00727337
Study groupRoleWhat they receive
LACE-DVDExperimentalParticipants will complete the LACE training, however, not in an interactive computer mode but through a static DVD mode
Receives: Behavioral: Lace-DVD
LACE-COMPUTERExperimentalParticipants will complete a computer-based auditory training program (i.e., LACE)
Receives: Behavioral: LACE-computer
PLACEBO-DIRECTED LISTENINGActive comparatorParticipants will complete a directed listening to books on CD treatment
Receives: Behavioral: PLACEBO-Directed listening
CONTROLActive comparatorParticipants will be provided with hearing aids
Receives: Behavioral: CONTROL

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Words-in-Noise Test (WIN) Change

    Monosyllabic words (NU-6 female version) with a carrier phrase were presented auditory only in a multitalker babble.The participant is asked to repeat the last word of each phrase. The total number of correct words is input into the Spearman-Karber equation to derive a 50% point. This is the signal-to-noise ratio in dB that an individual requires to get 50% of the words correct. This test was completed at baseline and follow up visits.

    Measured: Baseline, immediate post-intervention (up to 2 to 6 weeks), 6 month follow up

Secondary outcomes (2)
  1. Abbreviated Profile of Hearing Aid Benefit (APHAB) Change

    The Abbreviated Profile of Hearing Aid Performance (APHAP; Cox \& Alexander 1995) was used to assess activity limitations and the Hearing Handicap Inventory for the Elderly or Adults (HHI; Ventry \& Weinstein 1982; Newman et al. 1990) was used to assess participation restrictions. The APHAP is a 24-item questionnaire that documents hearing difficulties in specified listening situations. The items are answered on a 7-point scale from 'Always' (or 99%) to 'Never' (or 1%) with higher scores indicating greater reported hearing difficulty. The APHAP global score that ranges from 1 to 99 was used for all analyses.

    Measured: Baseline, immediate post-intervention (up to 2 to 6 weeks), 6 month follow up

  2. Hearing Handicap Inventory for the Elderly (HHI) Change

    The HHI is a 25-item questionnaire that assesses the social and emotional consequences of hearing loss. The HHI for the elderly is for individuals age 65 years and older (Ventry \& Weinstein 1982); the HHI for adults is for individuals aged 64 years and younger (Newman et al. 1990). The versions differ in the wording of three questions. The participants were asked to complete the appropriate HHI for aided listening to reflect their residual hearing handicap. HHI items are answered on a scale of Yes (4 points), Sometimes (2 points) and No (0 points), with higher scores indicating greater reported hearing handicap. Total HHI scores, which can range from 0 to 100, were used for all analyses.

    Measured: Baseline, immediate post-intervention (up to 2 to 6 weeks), 6 month follow up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Aug 2008 (estimated)
  2. Study startJan 2009
  3. Primary completionApr 2011
  4. Study completionDec 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
279 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00727337
Sponsor's protocol ID
C6303-R
Acronym
LACE
Status last verified
Jun 2018
First submitted
30 Jul 2008
Last updated
18 Jul 2018
Data monitoring committee
No

Publications

  • Chisolm TH, Saunders GH, Frederick MT, McArdle RA, Smith SL, Wilson RH. Learning to listen again: the role of compliance in auditory training for adults with hearing loss. Am J Audiol. 2013 Dec;22(2):339-42. doi: 10.1044/1059-0889(2013/12-0081).

    PubMed 24018575
  • Saunders GH, Smith SL, Chisolm TH, Frederick MT, McArdle RA, Wilson RH. A Randomized Control Trial: Supplementing Hearing Aid Use with Listening and Communication Enhancement (LACE) Auditory Training. Ear Hear. 2016 Jul-Aug;37(4):381-96. doi: 10.1097/AUD.0000000000000283.

    PubMed 26901263

Questions about this trial

What is this clinical trial studying?

A study testing LACE-computer and Lace-DVD in people with Hearing Loss, run by VA Office of Research and Development at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 13 Jan 2015). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Words-in-Noise Test (WIN) Change (time frame: Baseline, immediate post-intervention (up to 2 to 6 weeks), 6 month follow up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00727337, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jul 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in